The Enterprise Value as of December 2025 (TTM) for Synmosa Biopharma Corporation (4114.TWO) is 16.73B

According to Synmosa Biopharma Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 16.73B. This represents a change of 15.53% compared to the average of 14.48B of the last 4 quarters.

Synmosa Biopharma Corporation (4114.TWO) Historical Enterprise Value (quarterly & annually)

How has 4114.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Synmosa Biopharma Corporation over the last ten years is 10.33B. The current 16.73B Enterprise Value has changed 16.08% with respect to the historical average. Over the past ten years (40 quarters), 4114.TWO's Enterprise Value was at its highest in in the June 2025 quarter at 17.30B. The Enterprise Value was at its lowest in in the December 2022 quarter at 10.88B.

Synmosa Biopharma Corporation (4114.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Synmosa Biopharma Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Synmosa Biopharma Corporation (4114.TWO) Average Enterprise Value

How has 4114.TWO Enterprise Value performed in the past?

The current Enterprise Value of Synmosa Biopharma Corporation (4114.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Synmosa Biopharma Corporation (4114.TWO) Enterprise Value vs. Peers

How is 4114.TWO’s Enterprise Value compared to its peers?

Synmosa Biopharma Corporation’s Enterprise Value is greater than Grape King Bio Ltd (15.54B), greater than Handa Pharmaceuticals, Inc. (15.89B), greater than YungShin Global Holding Corporation (14.09B), less than TTY Biopharm Company Limited (20.44B), less than Great Tree Pharmacy Co., Ltd. (19.48B), less than Alar Pharmaceuticals Inc. (18.38B), greater than ScinoPharm Taiwan, Ltd. (11.32B), greater than Excelsior Medical Co., Ltd. (13.29B), greater than Foresee Pharmaceuticals Co., Ltd. (11.88B), greater than Standard Chem & Pharm Co. Ltd. (10.40B),

Build a custom stock screener for Synmosa Biopharma Corporation (4114.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synmosa Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synmosa Biopharma Corporation (4114.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synmosa Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.